I spy apraxic eyes in spinocerebellar ataxia type 2: A false-negative ataxia panel

Authors

  • Amanda J. Thompson MD,,

    1. Center for Movement Disorders and Neurorestoration, Department of Neurology, University of Florida College of Medicine, Gainesville, Florida, USA
    Search for more papers by this author
  • Sankarasubramoney H. Subramony MD,,

    1. McKnight Brain Institute, Department of Neurology, University of Florida College of Medicine, Gainesville, Florida, USA
    Search for more papers by this author
  • Michael S. Okun MD

    Corresponding author
    1. Center for Movement Disorders and Neurorestoration, Department of Neurology, University of Florida College of Medicine, Gainesville, Florida, USA
    • Correspondence to: Dr. Michael S. Okun, University of Florida College of Medicine, Department of Neurology, Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville, FL 32607, USA; okun@neurology.ufl.edu

    Search for more papers by this author

  • Funding agencies: Funded internally by the University of Florida College of Medicine, Department of Neurology.

  • Relevant conflicts of interest/financial disclosures: Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past >36 months has received no support from industry. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology. Dr. Okun has participated in CME activities on movement disorders in the last 36 months sponsored by PeerView, Prime, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria.

No abstract is available for this article.

Ancillary